2023
Trends in and Risk Factors for Recurrent Clostridioides difficile Infection, New Haven County, Connecticut, USA, 2015–2020 - Volume 29, Number 5—May 2023 - Emerging Infectious Diseases journal - CDC
Okafor C, Clogher P, Olson D, Niccolai L, Hadler J. Trends in and Risk Factors for Recurrent Clostridioides difficile Infection, New Haven County, Connecticut, USA, 2015–2020 - Volume 29, Number 5—May 2023 - Emerging Infectious Diseases journal - CDC. Emerging Infectious Diseases 2023, 29: 877-887. PMID: 37081745, PMCID: PMC10124664, DOI: 10.3201/eid2905.221294.Peer-Reviewed Original ResearchConceptsRecurrent Clostridioides difficile infectionClostridioides difficile infectionNew Haven CountyPopulation-based laboratory surveillanceRisk factorsMedical risk factorsC. difficile casesHospital-onset casesNitrofurantoin useLaboratory surveillanceHealthcare systemIncreasing burdenTime trendsAssociated variablesIdentified factorsInfectionCOVID-19 pandemicMultiple regressionIncidenceCDCCountyConnecticutMalignancy
2021
Increases in Human Papillomavirus Testing Preceding Diagnosis of Cervical Precancer in 5 US States, 2008–2016
Cleveland AA, Gargano JW, Griffin MR, Park IU, Niccolai LM, Bennett NM, Pemmaraju M, Fink D, Brackney M, Scahill M, Ehlers SJ, Unger ER, Markowitz LE, Group T. Increases in Human Papillomavirus Testing Preceding Diagnosis of Cervical Precancer in 5 US States, 2008–2016. Journal Of Lower Genital Tract Disease 2021, 25: 192-198. PMID: 33797511, DOI: 10.1097/lgt.0000000000000606.Peer-Reviewed Original ResearchConceptsHPV testProportion of womenCervical precancerCytology resultsAge groupsHuman papillomavirus testingAtypical squamous cellsAtypical glandular cellsCervical intraepithelial neoplasiaWomen 30 yearsCross-sectional analysisHPV testingCervical diseaseIntraepithelial lesionsIntraepithelial neoplasiaSquamous cellsLaboratory surveillanceMost womenUnknown significanceGlandular cellsDiagnosisPrecancerWomenCIN2Years
2018
Trends in High-grade Cervical Lesions and Cervical Cancer Screening in 5 States, 2008–2015
Gargano JW, Park IU, Griffin MR, Niccolai LM, Powell M, Bennett NM, Jones ML, Whitney E, Pemmaraju M, Brackney M, Abdullah N, Scahill M, Dahl RM, Cleveland AA, Unger ER, Markowitz LE, Blankenship S, Allen S, Meek J, Higgins K, Hadler J, Sosa L, Saadeh K, Williamson A, Fink D, Silverberg M, Laing R, Schafer S, Oktapodas M, Felsen C. Trends in High-grade Cervical Lesions and Cervical Cancer Screening in 5 States, 2008–2015. Clinical Infectious Diseases 2018, 68: 1282-1291. PMID: 30137283, PMCID: PMC6783904, DOI: 10.1093/cid/ciy707.Peer-Reviewed Original ResearchConceptsCervical cancer screeningIncidence rate ratiosCancer screeningCervical cancer screening recommendationsPopulation-based laboratory surveillanceAge groupsHigh-grade cervical lesionsHuman papillomavirus vaccine uptakeCancer screening recommendationsCervical intraepithelial neoplasiaPercent of womenHPV vaccinationScreening recommendationsIntraepithelial neoplasiaVaccine uptakeCervical lesionsLaboratory surveillanceCIN2Population-level impactWomenRate ratioSignificant decreaseYearsScreeningAdenocarcinoma
2011
Changing Disparities in Invasive Pneumococcal Disease by Socioeconomic Status and Race/Ethnicity in Connecticut, 1998–2008
Soto K, Petit S, Hadler JL. Changing Disparities in Invasive Pneumococcal Disease by Socioeconomic Status and Race/Ethnicity in Connecticut, 1998–2008. Public Health Reports 2011, 126: 81-88. PMID: 21836741, PMCID: PMC3150133, DOI: 10.1177/00333549111260s313.Peer-Reviewed Original ResearchConceptsRace/ethnicityNon-PCV7 serotypesSocioeconomic statusIncidence differenceCensus tract socioeconomic statusInvasive pneumococcal disease incidenceNeighborhood poverty levelInvasive pneumococcal diseasePneumococcal conjugate vaccinePneumococcal disease incidenceSterile body sitesRates of IPDHigh-poverty census tractsAbsence of vaccinesHigh rateIPD incidencePneumococcal diseaseConjugate vaccinePneumococcal isolatesTarget preventionLaboratory surveillancePoverty levelPercentage of peopleWhite peopleBody sites
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply